Medical Oncology and Blood Disorders, LLP

Manchester, Connecticut 06040

0 studies enrolling now · 3 studies all time

What they study most

Chronic Myeloid Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma

Studies at this site

• Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
• Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. — Completed
• Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed